XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK PLANS (Tables)
6 Months Ended
Jun. 30, 2019
STOCK PLANS [Abstract]  
Stock Option Activity
The following table presents the activity related to stock options for the three months ended June 30, 2019.

 
 
Number of
Shares
  
Weighted
Average
Exercise Price
  
Aggregate
Intrinsic Value
  
Weighted
Average
Remaining
Contractual
Term (in years)
 
Options outstanding at Beginning of  Period
  
405,137
  
$
8.72
       
Granted
  
   
       
Expired
  
   
       
Cancelled / Forfeited
  
   
       
Exercised
  
   
       
Options outstanding at End of Period
  
405,137
  
$
8.72
  
$
1,192,539
   
6.91
 
Exercisable (vested) at End of Period
  
224,595
  
$
6.95
  
$
1,038,576
   
5.46
 

The following table presents the activity related to stock options for the six months ended June 30, 2019.

 
 
Number of
Shares
  
Weighted
Average
Exercise Price
  
Aggregate
Intrinsic Value
  
Weighted
Average
Remaining
Contractual
Term (in years)
 
Options outstanding at Beginning of  Period
  
329,160
  
$
8.23
       
Granted
  
77,666
  
$
10.86
       
Expired
  
  
$
       
Cancelled / Forfeited
  
(1,689
)
  
12.41
       
Exercised
  
   
       
Options outstanding at End of Period
  
405,137
  
$
8.72
  
$
1,192,539
   
6.91
 
Exercisable (vested) at End of Period
  
224,595
  
$
6.95
  
$
1,038,576
   
5.46
 
Weighted Average Assumptions Used in Valuing Stock Options Granted
A summary of the weighted average assumptions used in valuing stock options during the three and six months ended June 30, 2019 is presented below:

 
 
Three Months Ended
June 30, 2019*
  
Six Months Ended
June 30, 2019
 
Risk Free Interest Rate
  
   
2.47
%
 
        
Expected Dividend Yield
  
   
0.00
%
 
        
Expected Life in Years
  
   
5
 
 
        
Expected Price Volatility
  
   
11.86
%
Activity Related to Restricted Stock
The following table presents the activity related to non-vested restricted stock for the three months ended June 30, 2019.

 
 
Number of
Shares
  
Weighted
Average
Grant Date Fair Value
  
Aggregate
Intrinsic Value
  
Weighted
Average
Remaining
Contractual
Term (in years)
 
Non-vested Restricted stock outstanding at Beginning of  Period
  
126,731
  
$
10.19
       
Granted
  
  

       
Cancelled / Forfeited
  
(1,969
)
 

11.10
       
Exercised/Released/Vested
  

  
       
Non-vested restricted stock outstanding at End of Period
  
124,762
  
$
10.18
  
$
1,434,763
   
2.94
 

The following table presents the activity related to non-vested restricted stock for the six months ended June 30, 2019.

 
 
Number of
Shares
  
Weighted
Average
Grant Date Fair Value
  
Aggregate
Intrinsic Value
  
Weighted
Average
Remaining
Contractual
Term (in years)
 
Non-vested Restricted stock outstanding at Beginning of  Period
  
118,391
  
$
8.94
       
Granted
  
42,262
  

10.86
       
Cancelled / Forfeited
  
(1,969
)
 

11.10
       
Exercised/Released/Vested
  
(33,922
)
  
6.64
       
Non-vested restricted stock outstanding at End of Period
  
124,762
  
$
10.18
  
$
1,434,763
   
2.94
 
Weighted Average Assumptions Used in Valuing ESPP
A summary of the weighted average assumptions used in valuing ESPP issuances during the three and six months ended June 30, 2019 is presented below.

 
 
Three Months Ended
June 30, 2019
  
Six Months Ended
June 30, 2019
 
Risk Free Interest Rate
  
2.67
%
  
2.67
%
 
        
Expected Dividend Yield
  
0.00
%
  
0.00
%
 
        
Expected Life in Years
  
1.00
   
1.00
 
 
        
Expected Price Volatility
  
8.47
%
  
8.47
%